Pages that link to "Q33209363"
Jump to navigation
Jump to search
The following pages link to Potential and opportunities for use of recombinant lactic acid bacteria in human health (Q33209363):
Displaying 34 items.
- Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment (Q21562212) (← links)
- Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium (Q33496351) (← links)
- Prophylaxis of experimentally induced ovomucoid allergy in neonatal pigs using Lactococcus lactis (Q33764060) (← links)
- Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization (Q33864114) (← links)
- Biography of Todd R. Klaenhammer (Q33932580) (← links)
- Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice (Q35690028) (← links)
- Modelling strategies for the industrial exploitation of lactic acid bacteria (Q36343560) (← links)
- Actual concept of "probiotics": is it more functional to science or business? (Q36699182) (← links)
- Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria (Q37103921) (← links)
- Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria (Q37111626) (← links)
- Genome analysis of food grade lactic Acid-producing bacteria: from basics to applications (Q37185713) (← links)
- Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity (Q37215818) (← links)
- Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. (Q37461382) (← links)
- Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses (Q37545006) (← links)
- The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases (Q37729525) (← links)
- In vitro degradation of oxalate by recombinant Lactobacillus plantarum expressing heterologous oxalate decarboxylase. (Q39407773) (← links)
- Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen (Q40428119) (← links)
- Repetitive, marker-free, site-specific integration as a novel tool for multiple chromosomal integration of DNA. (Q41844630) (← links)
- Biocontainment strategies for live lactic acid bacteria vaccine vectors (Q42161475) (← links)
- Integrative expression system for delivery of antibody fragments by lactobacilli. (Q42706463) (← links)
- A new plasmid vector for DNA delivery using lactococci (Q43176145) (← links)
- In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells (Q45876837) (← links)
- Heterologous expression of oxalate decarboxylase in Lactobacillus plantarum NC8. (Q46301157) (← links)
- In vitro assessment of functional properties of lactic acid bacteria isolated from faecal microbiota of healthy dogs for potential use as probiotics. (Q46577670) (← links)
- Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection (Q47132462) (← links)
- Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant (Q47348407) (← links)
- Simultaneous lactic acidification and coagulation by using recombinant Lactococcus lactis strain (Q47845498) (← links)
- Metabolic engineering of Lactococcus lactis influence of the overproduction of lipase enzyme (Q50229264) (← links)
- Mobile group II intron based gene targeting in Lactobacillus plantarum WCFS1. (Q50658168) (← links)
- Development of lactococcal GEM-based pneumococcal vaccines (Q79325600) (← links)
- Haemagglutination induced by Bordetella pertussis filamentous haemagglutinin adhesin (FHA) is inhibited by antibodies produced against FHA(430-873) fragment expressed in Lactobacillus casei (Q79361056) (← links)
- Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria (Q80735256) (← links)
- Influence of the route of administration on immunomodulatory properties of bovine beta-lactoglobulin-producing Lactobacillus casei (Q84346983) (← links)
- Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice (Q84734056) (← links)